General Information
Revision date
2015-07-22
Product name
Osteo-Form
Product Synonyms
Chewable Tablets
1.2.1 Relevant identified uses
For use as an aid in the prevention of dietary deficiencies of calcium, phosphorous and vitamins A and D in dogs and cats
Emergency telephone
(800) 222-1222
Icons in SDS
Company Information
company name
LLOYD, Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
WARNING EYE: This product is not expected to irritate the eyes. SKIN CONTACT: This product is not expected to irritate the skin. INGESTION: This has not been evaluated. INHALATION: Inhalation exposure under normal conditions of use is not likely to cause adverse effects, however irritation may occur if use conditions generate dust. Dicalcium Phosphate--Oral LD50 (rat) 10,000 mg/kg; Dermal LD50 (rabbit) >7940 mg/kg Glycerin--Oral LD50 (rat) 17-27.2 g/kg; Rabbit (dermal) 500 mg/24 hr moderate irritation SIGNS AND SYMPTOMS OF EXPOSURE: Glycerin: Repeated excessive exposure may cause kidney and liver effects, and increased fat levels in blood. Observations in animals include gastrointestinal irritation with very large oral doses. Birth defects are unlikely. Exposures having no adverse effects on the mother should have no effect on the fetus. Reproduction studies indicate that glycerin does not directly interfere with reproduction in animals. When animals were maintained on synthetic diets or dosed at extremely high levels, reproduction in females was affected -- perhaps due to altered nutritional states. INFORMATION ON INGREDIENTS (% w/w), unless otherwise noted EXPOSURE LIMITS, ppm
